More recently, uNGAL monitoring studies revealed that NGAL also predicted the severity of CI-AKI into CKD and/or hemodialysis progression, demonstrating that NGAL is potentially superior compared to conventional markers of nephropathy after invasive coronary procedures with contrast agents [86,87,88,89,90]. This evidence concerns the gene LCN2 and chronic kidney disease.